Skip to main
ALAB

ALAB Stock Forecast & Price Target

ALAB Analyst Ratings

Based on 18 analyst ratings
Buy
Strong Buy 33%
Buy 33%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Astera Labs is well positioned because its connectivity solutions sit at the center of AI and cloud infrastructure, where demand is being driven by GenAI buildouts, hyperscaler spending, and rising PCIe Gen 6 adoption. The company is showing strong execution with 1Q26 revenue of $308.4MM, +93% Y/Y, gross margin of 76.4%, and guidance for $360MM at the midpoint in JunQ, signaling broad-based strength across Aries, Taurus, and Scorpio. Its outlook is further supported by Scorpio-X initial volume shipments and the prospect of larger volume ramps later, which should expand average selling prices and reinforce a premium-margin business model.

Bears say

Astera Labs is viewed negatively because revenue is highly concentrated, with the AWS warrant agreement underscoring dependence on a handful of hyperscalers just as cloud capex cuts could weaken AI-related demand. Gross margin also faces pressure from margin headwinds, with quarter-over-quarter decline driven by product mix and an operating expense step-up offsetting any sequential operating margin benefit. The outlook is further clouded by severe competition from Broadcom, Marvell, and Credo in retimers and AECs, while slower global growth and uncertainty around Scale-Up Ethernet versus retimer demand threaten both growth and share.

ALAB has been analyzed by 18 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Astera Labs Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Astera Labs Inc (ALAB) Forecast

Analysts have given ALAB a Buy based on their latest research and market trends.

According to 18 analysts, ALAB has a Buy consensus rating as of Oct 24, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $341.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $341.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Astera Labs Inc (ALAB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.